CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,110 enrolled
Drug / intervention
SULT4A1-1 genetic testgenetic
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01245348
NCT01245348N/ACompleted
CompareCT.gov

Relative Effectiveness of Schizophrenia Therapy (REST) Study

Medco Health Solutions, Inc.·observational·Posted Nov 22, 2010·Updated Feb 25, 2013

In Brief

An observational study evaluating SULT4A1-1 genetic test for Schizophrenia and Bipolar Disorder. Completed, enrolled 1,110 participants across 1 site.

Detailed Summary

The purpose of this study is to validate that SULT4A1-1 status stratification improves responses to atypical antipsychotics in schizophrenia and to extend these findings into bipolar disorder.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSchizophrenia, Bipolar Disorder
CountriesUnited States
CollaboratorsSureGene, LLC

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedNov 22, 2010
Enrollment StartDec 1, 2010
Primary CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 15.6 years ago

Interventions

SULT4A1-1 genetic testgenetic

SULT4A1-1 haplotype result (+/-)